These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 30101724

  • 1. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
    Brar V, Kaur G.
    Pharm Nanotechnol; 2018; 6(3):180-191. PubMed ID: 30101724
    [Abstract] [Full Text] [Related]

  • 2. Thiolated okra chitosan nanoparticles: preparation and optimisation as intranasal drug delivery agents.
    Brar V, Kaur G.
    J Microencapsul; 2020 Dec; 37(8):624-639. PubMed ID: 33092412
    [Abstract] [Full Text] [Related]

  • 3. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [Abstract] [Full Text] [Related]

  • 4. Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation.
    Newton AM, Indana VL, Kumar J.
    Int J Biol Macromol; 2015 Aug; 79():290-9. PubMed ID: 25936283
    [Abstract] [Full Text] [Related]

  • 5. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
    Shah B, Khunt D, Misra M, Padh H.
    Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
    [Abstract] [Full Text] [Related]

  • 6. Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.
    Haque S, Md S, Fazil M, Kumar M, Sahni JK, Ali J, Baboota S.
    Carbohydr Polym; 2012 Jun 05; 89(1):72-9. PubMed ID: 24750606
    [Abstract] [Full Text] [Related]

  • 7. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Curr Drug Discov Technol; 2019 Jun 05; 16(4):417-425. PubMed ID: 29669501
    [Abstract] [Full Text] [Related]

  • 8. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
    Qureshi M, Aqil M, Imam SS, Ahad A, Sultana Y.
    Curr Drug Deliv; 2019 Jun 05; 16(2):123-135. PubMed ID: 30317997
    [Abstract] [Full Text] [Related]

  • 9. Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation.
    Ramreddy S, Janapareddi K.
    Drug Dev Ind Pharm; 2019 Jan 05; 45(1):147-158. PubMed ID: 30230386
    [Abstract] [Full Text] [Related]

  • 10. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
    Jafarieh O, Md S, Ali M, Baboota S, Sahni JK, Kumari B, Bhatnagar A, Ali J.
    Drug Dev Ind Pharm; 2015 Jan 05; 41(10):1674-81. PubMed ID: 25496439
    [Abstract] [Full Text] [Related]

  • 11. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N, Ahmad R, Alam MA, Ahmad FJ.
    Drug Res (Stuttg); 2018 Oct 05; 68(10):584-595. PubMed ID: 29669380
    [Abstract] [Full Text] [Related]

  • 12. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia.
    Ahmad N, Ahmad R, Naqvi AA, Alam MA, Ashafaq M, Samim M, Iqbal Z, Ahmad FJ.
    Int J Biol Macromol; 2016 Oct 05; 91():640-55. PubMed ID: 27264648
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
    Youssef NAHA, Kassem AA, Farid RM, Ismail FA, El-Massik MAE, Boraie NA.
    Int J Pharm; 2018 Sep 05; 548(1):609-624. PubMed ID: 30033394
    [Abstract] [Full Text] [Related]

  • 15. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS, Farid RM, ElGamal SS.
    Drug Dev Ind Pharm; 2015 Sep 05; 41(12):2055-68. PubMed ID: 26133084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):6-15. PubMed ID: 22561106
    [Abstract] [Full Text] [Related]

  • 18. Carboxymethyl gum kondagogu-chitosan polyelectrolyte complex nanoparticles: preparation and characterization.
    Kumar A, Ahuja M.
    Int J Biol Macromol; 2013 Nov 30; 62():80-4. PubMed ID: 23994791
    [Abstract] [Full Text] [Related]

  • 19. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
    Javia A, Thakkar H.
    J Microencapsul; 2017 Nov 30; 34(7):644-658. PubMed ID: 28862072
    [Abstract] [Full Text] [Related]

  • 20. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting.
    Kumbhar SA, Kokare CR, Shrivastava B, Gorain B, Choudhury H.
    Int J Pharm; 2020 Aug 30; 586():119499. PubMed ID: 32505580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.